IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Foresite Capital Management II, LLC

Q4 2020 Holdings

Filed 2021-02-16 | 4 holdings | $378.7K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
10x Genomics, Inc.(TXG)CLASS A COMMON88025U109$354.5K2,503,52893.6%
Epizyme, Inc.(EPZMEUR)COM29428V104$10.9K1,000,0022.9%
Novavax, Inc.(NVAX)COM670002401$7.5K67,3732.0%
Acceleron Pharma Inc.(XLRN)COM00434H108$5.9K45,8841.5%